Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF.

Smad4 is involved in cancer progression and metastasis. Using a pair of human syngeneic epithelial ovarian cancer cells with low (HO-8910) and high (HO-8910PM) metastatic abilities, we aimed to reveal the role of Smad4 in ovarian cancer metastasis in vitro. Smad4 was down-regulated in HO-8910PM cell line relative to HO-8910 by implicating Smad4 was probably a potential tumor suppressor gene for ovarian cancer. Re-expression of Smad4 decreased the migration ability and inhibited the invasion capacity of HO-8910PM, while promoted the cell adhesion capacity for HO-8910PM. The stable expression of Smad4 increased the expression of E-cadherin, reduced the expression of plasminogen activator inhibitor-1 (PAI-1) and slightly down-regulated the expression of VEGF. Smad4 suppresses human ovarian cancer cell metastasis potential through its effect on the expressions of PAI-1, E-cadherin and VEGF. Results from current work implicate Smad4 might suppress the invasion and metastasis of human ovarian tumor cells through a TGF-Beta/Smad-mediated pathway.

[1]  K. Venkatasubbarao,et al.  Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells. , 2008, Cancer research.

[2]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[3]  R. Kemler.  From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. , 1993, Trends in genetics : TIG.

[4]  George Coukos,et al.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.

[5]  C. Heldin,et al.  Smad regulation in TGF-beta signal transduction. , 2001, Journal of cell science.

[6]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[7]  S. Bao,et al.  Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways , 2009, Cell biology international.

[8]  Peter D. Kwong,et al.  Structural basis of cell-cell adhesion by cadherins , 1995, Nature.

[9]  Cuirong Sun,et al.  Cytotoxic Activity and Constituents of the Volatile Oil from the Roots of Patrinia scabra Bunge , 2005, Chemistry & biodiversity.

[10]  G. Berx,et al.  Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells , 2002, Oncogene.

[11]  C. Hill,et al.  Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. , 2002, Molecular cell.

[12]  B. Nielsen,et al.  Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor‐1 in colon cancer liver metastases , 2009, International journal of cancer.

[13]  J. Benhattar,et al.  Loss of Smad4 expression predicts liver metastasis in human colorectal cancer. , 2007, Oncology reports.

[14]  Ming Chen,et al.  TGF-beta induces fibroblast activation protein expression; fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM [corrected]. , 2009, Experimental and molecular pathology.

[15]  Hong-xiang Sun,et al.  A New Cytotoxic, Apoptosis‐Inducing Triterpenoid from the Rhizomes of Astilbe chinensis , 2008, Chemistry & biodiversity.

[16]  F. Castellino,et al.  Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. , 2000, Cancer research.

[17]  H. Augustin,et al.  Cancer: Blood vessels kept quiet , 2009, Nature.

[18]  T. Gelehrter,et al.  Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the acute phase response. , 1994, The Journal of biological chemistry.

[19]  L. Wang,et al.  Expression of DPC4/Smad4 in non-small-cell lung carcinoma and its relationship with angiogenesis. , 2008, Neoplasma (Bratislava).

[20]  Jun Shi,et al.  Effect of hypoxia and re-oxygenation on cell invasion and adhesion in human ovarian carcinoma cells. , 2008, Oncology reports.

[21]  Junfeng Zhang,et al.  PGC-1α induces apoptosis in human epithelial ovarian cancer cells through a PPARγ-dependent pathway , 2007, Cell Research.

[22]  N. Ferrara,et al.  VEGF inhibition: insights from preclinical and clinical studies , 2008, Cell and Tissue Research.

[23]  Z. Gu,et al.  Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization. , 1999, Journal of experimental & clinical cancer research : CR.

[24]  Erik Sahai,et al.  Mechanisms of cancer cell invasion. , 2005, Current opinion in genetics & development.

[25]  Liying Gu,et al.  TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression. , 2009, Cancer letters.

[26]  Hongchuan Jin,et al.  In vitro biological activities of transmembrane superantigen staphylococcal enterotoxin A fusion protein , 2004, Cancer Immunology, Immunotherapy.

[27]  R. Jain.  A new target for tumor therapy. , 2009, The New England journal of medicine.

[28]  Junfeng Zhang,et al.  PGC-1alpha induces apoptosis in human epithelial ovarian cancer cells through a PPARgamma-dependent pathway. , 2007, Cell research.

[29]  R. Wooster,et al.  Breast and ovarian cancer. , 2003, The New England journal of medicine.